AP

Ammber Pandey

Active Director Director DIN 02777567
DIN 02777567 First appointment Oct 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2009
Shareholding value •••• Premium profile

About Ammber Pandey

Data last updated:

Ammber Pandey is a Director at Alchemist Remedies Private Limited (since 2009). The company operates in Pharma. Alchemist Remedies Private Limited reported revenue of ₹7.72 Cr (FY 2025).

DIN 02777567
Primary Designation Director
Industry Pharma
First Appointment 13 Oct 2009
Oldest Company Age 17 yrs
Largest company Alchemist Remedies Private Limited · ₹7.72 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alchemist Remedies Private Limited U24230MP2009PTC022487
Director13 Oct 20092009₹7.72 Cr (FY 2025)Active

Board colleagues of Ammber Pandey

Directorship timeline

Open interactive timeline →
Alchemist Remedies Private Limited
Premium access

Shareholding and investment profile for Ammber Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ammber Pandey

Ammber Pandey currently holds 1 directorship: Alchemist Remedies Private Limited (Director, since 13 Oct 2009, revenue ₹7.72 Cr (FY 2025)).

Ammber Pandey was first appointed on 13 Oct 2009 as Director at Alchemist Remedies Private Limited.

The current boards of Ammber Pandey's companies include Ranjana Pandey (Alchemist Remedies Private Limited), Shiv Datta Pandey (Alchemist Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available